Meyka Pro banner
Lucy Scientific Discovery Inc.

Lucy Scientific Discovery Inc. Fundamental Analysis (NASDAQ: LSDI)

LSDINASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.51
$0.16(23.29%)
U.S. Market is Open · 14:50

Lucy Scientific Discovery Inc. Fundamental Analysis (NASDAQ: LSDI)

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) shows moderate financial fundamentals with a PE ratio of -0.72, profit margin of -1275.32%, and ROE of 181.47%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE181.47%
Cash Position25.65%
PEG Ratio0.01

Areas of Concern

Operating Margin-829.20%
We analyze LSDI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -119507.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-119507.9/100

We analyze LSDI's fundamental strength across five key dimensions:

Efficiency Score

Weak

LSDI struggles to generate sufficient returns from assets.

ROA > 10%
-1.02%

Valuation Score

Excellent

LSDI trades at attractive valuation levels.

PE < 25
-0.72
PEG Ratio < 2
0.01

Growth Score

Weak

LSDI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

LSDI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.38
Current Ratio > 1
1.41

Profitability Score

Weak

LSDI struggles to sustain strong margins.

ROE > 15%
181.47%
Net Margin ≥ 15%
-1275.32%
Positive Free Cash Flow
No

Key Financial Metrics

Is LSDI Expensive or Cheap?

P/E Ratio

LSDI trades at -0.72 times earnings. This suggests potential undervaluation.

-0.72

PEG Ratio

When adjusting for growth, LSDI's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Lucy Scientific Discovery Inc. at 1.40 times its book value. This may indicate undervaluation.

1.40

EV/EBITDA

Enterprise value stands at -0.14 times EBITDA. This is generally considered low.

-0.14

How Well Does LSDI Make Money?

Net Profit Margin

For every $100 in sales, Lucy Scientific Discovery Inc. keeps $-1275.32 as profit after all expenses.

-1275.32%

Operating Margin

Core operations generate -829.20 in profit for every $100 in revenue, before interest and taxes.

-829.20%

ROE

Management delivers $181.47 in profit for every $100 of shareholder equity.

181.47%

ROA

Lucy Scientific Discovery Inc. generates $-1.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Lucy Scientific Discovery Inc. generates limited operating cash flow of $-592.79K, signaling weaker underlying cash strength.

$-592.79K

Free Cash Flow

Lucy Scientific Discovery Inc. generates weak or negative free cash flow of $-634.47K, restricting financial flexibility.

$-634.47K

FCF Per Share

Each share generates $-0.36 in free cash annually.

$-0.36

FCF Yield

LSDI converts -5.04% of its market value into free cash.

-5.04%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.72

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.40

vs 25 benchmark

P/S Ratio

Price to sales ratio

128.68

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

181.47

vs 25 benchmark

ROA

Return on assets percentage

-1.02

vs 25 benchmark

ROCE

Return on capital employed

-0.96

vs 25 benchmark

How LSDI Stacks Against Its Sector Peers

MetricLSDI ValueSector AveragePerformance
P/E Ratio-0.7231.56 Better (Cheaper)
ROE18147.32%441.00% Excellent
Net Margin-127532.01%18300.00% Weak
Debt/Equity0.380.73 Strong (Low Leverage)
Current Ratio1.415.63 Neutral
ROA-102.39%1512.00% Weak

LSDI outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Lucy Scientific Discovery Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ